Trial Profile
Clinical Trials Insight: 700016897
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 25 Oct 2006
Price :
$35
*
At a glance
- Drugs ACE 393 (Primary)
- Indications Campylobacter infections; Traveller's diarrhoea
- Focus Adverse reactions
- Sponsors ACE BioSciences
- 25 Oct 2006 New trial record.